Why Join Intellia?
Our mission is to develop curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.
Beyond our science, we live our four core values: One, Explore, Disrupt, Deliver and feel strongly that you can achieve more at Intellia. We have a single-minded determination to excel and succeed together. We believe in the power of curiosity and pushing boundaries. We welcome challenging thoughts and imagination to develop innovative solutions. And we know that patients are counting on us to make the promise a reality, so we must maintain high standards and get it done.
We want all of our people to go beyond what is possible. We aren’t constrained by typical end rails, and we aren’t out to just “treat” people. We’re all in this for something more. We’re driven to cure and motivated for change. Just imagine the possibilities of what we can do together.
How You Will Achieve More With Intellia:
Intellia Therapeutics is seeking a Senior Director, Site Readiness and Field Reimbursement to lead a critical function in preparing for the successful launch of NTLA-2002, our groundbreaking investigational therapy in phase 3 of development for the treatment of hereditary angioedema (HAE).
This leader will develop and execute strategies to ensure sites are fully prepared to administer NTLA-2002, while also leading the field reimbursement team to eliminate access and reimbursement barriers for providers and patients.
The position level will be determined based on relevant experience.
Responsibilities:
Site Readiness
-
Develop and execute the operational framework to prepare sites for NTLA-2002 infusions, ensuring smooth onboarding and seamless integration into site workflows.
-
Establish and maintain relationships with healthcare institutions to assess site readiness and address logistical, operational, and training needs.
-
Work with institutions to support product P&T review and other processes to gain acceptance and utilization at the facility (e.g. EMR integration.)
-
Create scalable site preparation tools, protocols, and best practices to standardize processes across diverse healthcare settings.
-
Collaborate cross-functionally with internal teams, including medical affairs, commercial operations, market access, quality, and clinical development, to align on site needs and implementation plans.
-
Deep understanding of compliance and quality requirements related to site operational readiness to ensure Intellia abides by appropriate laws and regulations.
Field Reimbursement Leadership
-
Build and lead a high-performing field reimbursement team to proactively support providers and patients in overcoming access and reimbursement challenges.
-
Develop strategic solutions to address coverage, coding, and payment issues related to NTLA-2002.
-
Work closely with payers, providers, and patient advocacy groups to ensure NTLA-2002 is accessible and affordable.
-
Contribute to the creation of reimbursement tools, resources, and educational materials to support field teams and provider partners.
Access and Stakeholder Engagement
-
Serve as the primary liaison with key external stakeholders, including healthcare administrators, infusion centers, and reimbursement teams, to foster collaboration and address barriers.
-
Partner with market access and policy teams to monitor and respond to changes in reimbursement environments and healthcare policies impacting NTLA-2002.
-
Advocate for patients and providers by addressing challenges related to patient access and site readiness, ensuring a patient-centric approach to implementation.
Team leadership and Development
-
Recruit, manage, and mentor the site readiness and field reimbursement team, fostering a culture of accountability, innovation, and collaboration.
-
Set clear goals and key performance indicators (KPIs) for the team to ensure the successful execution of objectives.
-
Provide regular updates to executive leadership on site readiness, reimbursement challenges, and access-related progress.
About You:
-
Deep understanding of infusion-based therapies, site operations, and payer dynamics in the U.S. healthcare system.
-
Proven ability to develop and implement site readiness strategies and resolve reimbursement challenges.
-
Strong leadership skills, with experience building and managing high-performing teams.
-
Exceptional communication and relationship-building skills, with the ability to work effectively across internal teams and external stakeholders.
-
Willingness to travel as needed to engage with sites, field teams, and stakeholders. Travel may be up to 60%.
-
Familiarity with healthcare compliance regulations and payer reimbursement policies.
-
Strong problem-solving and analytical skills to navigate complex access and operational challenges.
-
Advanced degree (MBA, PharmD, PhD, MD) or equivalent in business, life sciences, public health, or a related field.
-
10+ years of experience in site readiness, field reimbursement, or market access in the biopharmaceutical or healthcare industry, including field reimbursement leadership.
-
Prior US launch experience is required
-
Experience in competitive rare diseases is required
-
Experience with cell and gene therapy or other highly specialized therapies desired.
-
Experience in HAE is desired.
#LI-SV1
#LI-Hybrid
Covid-19 Vaccination Policy: All Intellia employees, regardless of work location, are expected to follow all applicable federal, state, and local public health regulations and guidelines, and are strongly encouraged to follow all public health recommendations, including being vaccinated for COVID-19.
EEOC Statement: Intellia believes in a diverse environment, and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Intellia will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.
What We Do
Intellia Therapeutics is a leading genome editing company whose mission is to develop potentially curative gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.
We are focused on the development of proprietary therapeutics using a recently developed biological tool known as the CRISPR/Cas9 system. The promise of the CRISPR/Cas9 system is the driving force behind the creation of Intellia. Our founders have a shared belief that the CRISPR/Cas9 technology has the potential to transform medicine by permanently editing disease-associated genes in the human body with a single treatment course. This technology offers the potential for us to develop curative therapeutic options for patients with chronic diseases by addressing the underlying cause of the disease. It can bring new hope and cures to people who now have nowhere to turn for help.
Our combination of deep scientific expertise and clinical development experience, along with our leading intellectual property portfolio, puts Intellia in a unique position to unlock broad therapeutic applications of the CRISPR/Cas9 technology and create a new class of therapeutic products. Intellia has the right people, assets and ambitious vision needed to take full advantage of the CRISPR/Cas9 technology’s attributes – high potency, specificity, simplicity of use, broad applicability, and multifunctional programmability – and accelerate the advancement of curative products into the clinic.
View our social media community guidelines at https://www.intelliatx.com/terms-and-conditions/
